Improved Screening For Prostate Cancer

April 2017

Cancer

Country of origin: UK

Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The low positive predictive value of elevated PSA results in large numbers of unnecessary prostate biopsies. Researchers set out to determine whether a multivariable model including four kallikrein forms (total, free, and intact PSA, and human kallikrein 2 (hK2)) could predict prostate biopsy outcome in previously unscreened men with elevated total PSA.

The study cohort comprised 740 men in Göteborg, Sweden, undergoing biopsy during the first round of the European Randomised study of Screening for Prostate Cancer. The researchers calculated the area-under-the-curve (AUC) for predicting prostate cancer at biopsy. AUCs for a model including age and PSA (the 'laboratory' model) and age, PSA and digital rectal exam (the 'clinical' model) were compared with those for models that also included additional kallikreins.

Addition of free and intact PSA and hK2 improved AUC from 0.68 to 0.83 and from 0.72 to 0.84, for the laboratory and clinical models respectively. Using a 20% risk of prostate cancer as the threshold for biopsy would have reduced the number of biopsies by 424 (57%) and missed only 31 out of 152 low-grade and 3 out of 40 high-grade cancers.

The research concludes that multiple kallikrein forms measured in blood can predict the result of biopsy in previously unscreened men with elevated PSA. A multivariable model can determine which men should be advised to undergo biopsy and which might be advised to continue screening, but defer biopsy until there was stronger evidence of malignancy.

'A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomised Study of Prostate Cancer Screening in Göteborg, Sweden' is available online.

Resources

Manual for Cancer Services: Chemotherapy Measures October 2018 Following a three month consultation period the revised chemotherapy measures were published recently for inclusion in the...
QuitMedKit counseling and treatment of tobacco dependence October 2018 Tobacco use remains the number-one preventable cause of morbidity and mortality in the United States and worldwide. So it’s...
Sublux radiology app for all medical providers October 2018 What apps are available that teach the basics of plain radiography for more than just chest X-rays and ortho trauma? Are...
Study finds HPV from Oral Sex is linked to Throat Cancer September 2018 Oral sex increases the risk of transmitting the sexually transmitted human papillomavirus (HPV), suggests a new study...
Asian-language cancer information resource September 2018 About 4 million Asian Americans and Pacific Islanders have limited English proficiency, a disadvantage when it comes to...
inPractice® Oncology September 2018 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Achieving world-class cancer outcomes: a strategy for England 2015-2020 August 2018 The Independent Cancer Taskforce has published Achieving world-class cancer outcomes: a strategy for England 2015-2020....
Living with and beyond cancer - improving future survivorship services August 2018 The National Cancer Survivorship Initiative (NCSI) has published Living with and Beyond Cancer: Taking Action to Improve...
Cancer System Performance August 2018 A website allows cancer patients, their families and health care providers in Ontario, Canada, to access the province's...
Cancer statistics: availability and location July 2018 Document aims to provide an overview about cancer statistics, including information on statistics publicly available and...
Search by Keyword